BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38277753)

  • 1. Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.
    Fujii S; Hasegawa K; Maehara T; Kurppa KJ; Heikinheimo K; Warner KA; Maruyama S; Tajiri Y; Nör JE; Tanuma JI; Kawano S; Kiyoshima T
    Pathol Res Pract; 2024 Feb; 254():155148. PubMed ID: 38277753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Semaphorin 3A-AKT axis-mediated cell proliferation in salivary gland morphogenesis and adenoid cystic carcinoma pathogenesis.
    Fujii S; Fujimoto T; Hasegawa K; Nagano R; Ishibashi T; Kurppa KJ; Mikami Y; Kokura M; Tajiri Y; Kibe T; Wada H; Wada N; Kishida S; Higuchi Y; Kiyoshima T
    Pathol Res Pract; 2022 Aug; 236():153991. PubMed ID: 35759940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
    Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
    J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma.
    Wang R; Geng N; Zhou Y; Zhang D; Li L; Li J; Ji N; Zhou M; Chen Y; Chen Q
    Biomed Mater Eng; 2015; 26 Suppl 1():S2145-53. PubMed ID: 26405993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma.
    Branco KFCC; Ribeiro ALR; de Mendonça RP; de Jesus Viana Pinheiro J; da Silva Kataoka MS; Arnaud MVC; de Melo Alves Junior S
    Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):3039-3047. PubMed ID: 30367261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-kit induces epithelial-mesenchymal transition and contributes to salivary adenoid cystic cancer progression.
    Tang YL; Fan YL; Jiang J; Li KD; Zheng M; Chen W; Ma XR; Geng N; Chen QM; Chen Y; Liang XH
    Oncotarget; 2014 Mar; 5(6):1491-501. PubMed ID: 24721839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.
    Panaccione A; Zhang Y; Ryan M; Moskaluk CA; Anderson KS; Yarbrough WG; Ivanov SV
    Stem Cell Res; 2017 May; 21():160-166. PubMed ID: 28500913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma.
    Tang Y; Liang X; Zheng M; Zhu Z; Zhu G; Yang J; Chen Y
    Oral Oncol; 2010 Apr; 46(4):311-6. PubMed ID: 20219417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
    Ono J; Okada Y
    Odontology; 2018 Jul; 106(3):238-244. PubMed ID: 29243184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and localization of c-kit and epidermal growth factor receptor in different patterns of adenoid cystic carcinoma.
    Jain A; Shetty DC; Rathore AS; Kumar K
    J Cancer Res Ther; 2016; 12(2):834-9. PubMed ID: 27461660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-7 Inhibits Proliferation and Metastasis in Salivary Adenoid Cystic Carcinoma Through Wnt/β-Catenin Signaling.
    Ji H; Ding X; Zhang W; Zheng Y; Du H; Zheng Y; Song H; Li M; Jiang Y; Xie J; Wu M; Jiao P; Wang Z; Wu H; Zhong Y
    Cell Transplant; 2020; 29():963689720943583. PubMed ID: 32749148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
    Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
    Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma.
    Bell D; Roberts D; Karpowicz M; Hanna EY; Weber RS; El-Naggar AK
    Cancer Biol Ther; 2011 Oct; 12(7):569-73. PubMed ID: 21785271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior.
    Ivanov SV; Panaccione A; Brown B; Guo Y; Moskaluk CA; Wick MJ; Brown JL; Ivanova AV; Issaeva N; El-Naggar AK; Yarbrough WG
    Oncogene; 2013 Aug; 32(32):3698-710. PubMed ID: 23027130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
    Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
    Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
    Foo WC; Jo VY; Krane JF
    Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.